Health Canada
- Status: approved
Insulin Degludec and Insulin Aspart (Insulin Degludec and Insulin Aspart) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Huashan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.